Global Digital Health Company Celebrates Continued Growth with Rebrand to New Name Lumiio
Dataffinity Health unveils new name, new brand, and ambitious strategic growth plan
CALGARY, AB: Dataffinity Health, a boutique clinical services provider (formed in 2016) that specializes in real-world data collection products and services, has announced a full rebrand to position the company as a leader in global digital health. The rebrand comes on the heels of a major growth period for the company. In the last two years, the company has more than doubled in size and expanded its projects to have a global footprint in over 18 countries.
Supporting the refreshed strategic vision, the rebrand works to establish the company as a leader in digital health and data collection with the goal of accelerating health outcomes through data. The rebrand illustrates the guiding force that Lumiio has become to improve access to treatments and health care for patients across global health communities. Lumiio is working to fulfill the growing need in the global health community for improved real-world evidence data collection to drive towards a future of personalized and predictive medicine for those who need it most.
Central to its mission, Lumiio is improving health outcomes through a patient-centric approach by working with a growing group of stakeholders. This includes collaborations with some of the world’s largest pharmaceutical companies, patient organizations, and research institutes. Lumiio is eager to expand their global footprint to underserved markets, specifically targeting countries in Europe and South America.
"The rebrand and refreshed strategic vision are critical steps to the future growth and trajectory of Lumiio," said Blaine Penny, CEO. "We will continue to be driven to illuminate the way towards a future of personalized and predictive medicine for patient communities.”
Lumiio specializes in real-world data collection services that drive health outcomes. We connect stakeholders in health communities by aligning interests, and working towards the common goal of improving solutions for diagnostics, treatment, and care. At Lumiio, the social science leads the data science by combining classical research methods with innovative technologies and digital strategies. Lumiio does not own the data generated by our programs. We put people first and work to instill trust in those we serve, championing everyone involved in the collection of data and delivery of new treatments.
To learn more about Lumiio, visit www.lumiio.com
Ryan Wallace, Director Marketing & Operations